Better Coronavirus Stock: AstraZeneca vs. Moderna
Which company ranks as the leader in developing a potential COVID-19 vaccine? Opinions will vary, but you can bet that AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) will be two of the most frequently mentioned drugmakers.
Both AstraZeneca and Moderna have delivered solid gains so far this year. Moderna stands as the bigger winner, with its share price more than quadrupling compared to AstraZeneca's year-to-date increase of 17%. But which of these coronavirus stocks is the better pick now?
Image source: Getty Images.
Source Fool.com